{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:12:21Z","timestamp":1787317941803,"version":"build-2736575974"},"reference-count":40,"publisher":"BMJ","issue":"4","license":[{"start":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000},"content-version":"unspecified","delay-in-days":24,"URL":"https:\/\/creativecommons.org\/licenses\/by\/3.0\/igo\/"}],"funder":[{"DOI":"10.13039\/100020374","name":"Ministry of AYUSH, Government of India","doi-asserted-by":"publisher","award":["CD No. 190 dated 13\/08\/2021"],"award-info":[{"award-number":["CD No. 190 dated 13\/08\/2021"]}],"id":[{"id":"10.13039\/100020374","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2025,4,4]]},"published-print":{"date-parts":[[2025,4]]},"abstract":"\n Background<\/jats:title>\n \n Long covid describes a syndrome of persistent symptoms following COVID-19 and is responsible for substantial healthcare and economic burden. Currently, no effective treatments have been established. Ashwagandha (\n Withania somnifera (L.) Dunal<\/jats:italic>\n ) is a medicinal herb traditionally used in India for its immune-strengthening and anti-inflammatory properties. Withanolides, a family of steroid-derived molecules unique to Ashwagandha, have been shown to modulate inflammatory pathways in animal models, and several small randomised trials in humans support its effectiveness for reducing symptoms that are also associated with long covid. Therefore, this study aims to assess whether Ashwagandha is effective and safe for improving functional status and reducing symptom burden in adults living with long covid.\n <\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n A randomised double-blind placebo-controlled trial will be performed at participating general practice (GP) surgeries and long covid clinics across the UK. Individuals diagnosed with long covid will be screened for eligibility and then randomised 1:1 to take 1000\u2009mg daily of Ashwagandha root extract tablets (standardised to <0.9% withanolides) or matching placebo tablets for 3 months (target, n = 2500). Monthly online surveys will be performed to collect patient-reported outcomes, and monthly safety monitoring, including liver function tests, will be conducted by clinical site teams. The primary outcome of the Post-COVID Functional Status Scale score at 3 months will be assessed by baseline-adjusted ordinal logistic regression, according to a pre-published statistical analysis plan. The secondary outcomes included validated quality of life and long covid symptom scales, work status and productivity and adverse events. The trial has been approved as a Clinical Trial of an Investigational Medicinal Produce by the Medicines and Healthcare Regulatory Authority and by the NHS Research Ethics Committee and Health Research Authority.<\/jats:p>\n <\/jats:sec>\n \n Discussion<\/jats:title>\n Treatments for long covid are urgently needed. This trial will robustly evaluate the safety and efficacy of a candidate treatment with a promising efficacy and safety profile. If found to be effective, the findings will likely influence treatment guidelines and improve health outcomes in those living with long covid.<\/jats:p>\n <\/jats:sec>\n \n Trial registration number<\/jats:title>\n \n This trial was pre-registered on 15\/08\/2022:\n ISRCTN12368131<\/jats:ext-link>\n <\/jats:p>\n <\/jats:sec>","DOI":"10.1136\/bmjopen-2024-094526","type":"journal-article","created":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T09:00:43Z","timestamp":1745571643000},"page":"e094526","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Ashwagandha (\n Withania somnifera (L.) Dunal<\/i>\n ) for promoting recovery in long covid: protocol for a randomised placebo-controlled clinical trial (APRIL Trial)"],"prefix":"10.1136","volume":"15","clinical-trial-number":[{"clinical-trial-number":"isrctn12368131","registry":"10.18810\/isrctn"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7591-8065","authenticated-orcid":false,"given":"Poppy Alice Carson","family":"Mallinson","sequence":"first","affiliation":[{"name":"Department of Non-Communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manisha","family":"Joshi","sequence":"additional","affiliation":[{"name":"Department of Non-Communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahesh","family":"Mathpathi","sequence":"additional","affiliation":[{"name":"Department of Global Health and Development, London School of Hygiene & Tropical Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Perkins","sequence":"additional","affiliation":[{"name":"Centre for Global Chronic Conditions, Faculty of Epidemiology and Population Health, Department of Non-communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Clayton","sequence":"additional","affiliation":[{"name":"Department of Medical Statistics, London School of Hygiene & Tropical Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anoop SV","family":"Shah","sequence":"additional","affiliation":[{"name":"Centre for Global Chronic Conditions, Faculty of Epidemiology and Population Health, Department of Non-communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohini","family":"Mathur","sequence":"additional","affiliation":[{"name":"Centre for Primary Care and Public Health, Queen Mary University of London Wolfson Institute of Population Health, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Birk","sequence":"additional","affiliation":[{"name":"Department of Non-Communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arandeep","family":"Dhillon","sequence":"additional","affiliation":[{"name":"Department of Non-Communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8514-0381","authenticated-orcid":false,"given":"Judith","family":"Lieber","sequence":"additional","affiliation":[{"name":"Department of Medical Statistics, London School of Hygiene & Tropical Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sidra S","family":"Beg","sequence":"additional","affiliation":[{"name":"The University of Texas Health Science Center at Houston, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lily","family":"Hopkins","sequence":"additional","affiliation":[{"name":"Department of Non-Communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Archie","family":"Khan","sequence":"additional","affiliation":[{"name":"Department of Infection Biology, London School of Hygiene & Tropical Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0275-3228","authenticated-orcid":false,"given":"Shereen","family":"Allaham","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Public Health, UCL, London, UK"},{"name":"Aceso Global Health Consultants Ltd, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa TW","family":"Kam","sequence":"additional","affiliation":[{"name":"Department of Non-Communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9455-3751","authenticated-orcid":false,"given":"Shailen","family":"Sutaria","sequence":"additional","affiliation":[{"name":"Department of Non-Communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK"},{"name":"Global Public Health Unit, Queen Mary University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galib","family":"R","sequence":"additional","affiliation":[{"name":"All India Institute of Ayurveda, New Delhi, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Rajagopala","sequence":"additional","affiliation":[{"name":"All India Institute of Ayurveda, New Delhi, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amarjeet","family":"Bhamra","sequence":"additional","affiliation":[{"name":"All-Party Parliamentary Group on Indian Traditional Sciences, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geetha Krishnan G","family":"Pillai","sequence":"additional","affiliation":[{"name":"World Health Organization, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamlesh","family":"Khunti","sequence":"additional","affiliation":[{"name":"Diabetes Research Centre, University of Leicester, Leicester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanuja","family":"Nesari","sequence":"additional","affiliation":[{"name":"All India Institute of Ayurveda, New Delhi, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Kinra","sequence":"additional","affiliation":[{"name":"Department of Non-Communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,4,25]]},"reference":[{"key":"2025121400141917000_15.4.e094526.1","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101762","article-title":"The prevalence and long-term health effects of Long Covid among hospitalised and non-hospitalised populations: A systematic review and meta-analysis","volume":"55","author":"O\u2019Mahoney","year":"2023","journal-title":"EClinicalMedicine"},{"key":"2025121400141917000_15.4.e094526.2","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S2213-2600(21)00031-X","article-title":"NICE guideline on long COVID","volume":"9","author":"Venkatesan","year":"2021","journal-title":"Lancet Respir Med"},{"key":"2025121400141917000_15.4.e094526.3","unstructured":"(ONS) O for NS . Self-reported long covid symptoms. UK, 2023."},{"key":"2025121400141917000_15.4.e094526.4","unstructured":"Prevalence of ongoing symptoms following coronavirus (covid-19) infection in the uk. UK ONS) O for NS; 2023."},{"key":"2025121400141917000_15.4.e094526.5","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.101019","article-title":"Characterizing long COVID in an international cohort: 7 months of symptoms and their impact","volume":"38","author":"Davis","year":"2021","journal-title":"EClinicalMedicine"},{"key":"2025121400141917000_15.4.e094526.6","doi-asserted-by":"crossref","unstructured":"Mu Y , Dashtban A , Mizani MA , et al . Healthcare utilisation of 282,080 individuals with long covid over two years: a multiple matched control cohort analysis. SSRN [Preprint] 2023. doi:10.2139\/ssrn.4598962","DOI":"10.2139\/ssrn.4598962"},{"key":"2025121400141917000_15.4.e094526.7","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1080\/13504851.2022.2098239","article-title":"The impact of Long COVID on the UK workforce","volume":"30","author":"Reuschke","year":"2023","journal-title":"Appl Econ Lett"},{"key":"2025121400141917000_15.4.e094526.8","doi-asserted-by":"crossref","unstructured":"Interventions for the management of long covid (post-covid condition): living systematic review | The BMJ, Available: https:\/\/www.bmj.com\/content\/387\/bmj-2024-081318.long [Accessed 13 Feb 2025].","DOI":"10.1136\/bmj-2024-081318"},{"key":"2025121400141917000_15.4.e094526.9","unstructured":"Where are the long covid trials? - the lancet infectious diseases. Available: https:\/\/www.thelancet.com\/journals\/laninf\/article\/PIIS1473-3099(23)00440-1\/fulltext [Accessed 13 Feb 2025]."},{"key":"2025121400141917000_15.4.e094526.10","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2022.2076901"},{"key":"2025121400141917000_15.4.e094526.11","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s12017-016-8411-0","article-title":"Withania somnifera and Its Withanolides Attenuate Oxidative and Inflammatory Responses and Up-Regulate Antioxidant Responses in BV-2 Microglial Cells","volume":"18","author":"Sun","year":"2016","journal-title":"Neuromolecular Med"},{"key":"2025121400141917000_15.4.e094526.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2009.02.002"},{"key":"2025121400141917000_15.4.e094526.13","doi-asserted-by":"crossref","first-page":"112768","DOI":"10.1016\/j.jep.2020.112768","article-title":"Safety and clinical effectiveness of Withania Somnifera (Linn.) Dunal root in human ailments","volume":"255","author":"Tandon","year":"2020","journal-title":"J Ethnopharmacol"},{"key":"2025121400141917000_15.4.e094526.14","doi-asserted-by":"crossref","DOI":"10.1186\/s12970-015-0104-9","article-title":"Examining the effect of Withania somnifera supplementation on muscle strength and recovery: a randomized controlled trial","volume":"12","author":"Wankhede","year":"2015","journal-title":"J Int Soc Sports Nutr"},{"key":"2025121400141917000_15.4.e094526.15","doi-asserted-by":"crossref","DOI":"10.3390\/nu10111807","article-title":"Effects of an Aqueous Extract of Withania somnifera on Strength Training Adaptations and Recovery: The STAR Trial","volume":"10","author":"Ziegenfuss","year":"2018","journal-title":"Nutrients"},{"key":"2025121400141917000_15.4.e094526.16","doi-asserted-by":"crossref","unstructured":"P\u00e9rez-G\u00f3mez J , Villafaina S , Adsuar JC . Effects of Ashwagandha (Withania somnifera) on VO2max: A Systematic Review and Meta-Analysis. Nutrients 2020;12. doi:10.3390\/nu12041119","DOI":"10.3390\/nu12041119"},{"key":"2025121400141917000_15.4.e094526.17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0257843","article-title":"Effect of Ashwagandha (Withania somnifera) extract on sleep: A systematic review and meta-analysis","volume":"16","author":"Cheah","year":"2021","journal-title":"PLoS ONE"},{"key":"2025121400141917000_15.4.e094526.18","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph191911852","article-title":"Effects of Acute Ashwagandha Ingestion on Cognitive Function","volume":"19","author":"Xing","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"2025121400141917000_15.4.e094526.19","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.1002\/ptr.7598","article-title":"Does Ashwagandha supplementation have a beneficial effect on the management of anxiety and stress? A systematic review and meta-analysis of randomized controlled trials","volume":"36","author":"Akhgarjand","year":"2022","journal-title":"Phytother Res"},{"key":"2025121400141917000_15.4.e094526.20","doi-asserted-by":"publisher","DOI":"10.1177\/1534735412464551"},{"key":"2025121400141917000_15.4.e094526.21","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1177\/02698811231200023","article-title":"Exploring the efficacy and safety of a novel standardized ashwagandha (Withania somnifera) root extract (Witholytin\u00ae) in adults experiencing high stress and fatigue in a randomized, double-blind, placebo-controlled trial","volume":"37","author":"Smith","year":"2023","journal-title":"J Psychopharmacol"},{"key":"2025121400141917000_15.4.e094526.22","unstructured":"Verma SK , Kumar A . THERAPEUTIC uses of withania somnifera (ashwagandha). With a Note on Withanolides and Its Pharmacological Actions Review Article; 2011."},{"key":"2025121400141917000_15.4.e094526.23","doi-asserted-by":"crossref","first-page":"4445","DOI":"10.1007\/s00018-015-2012-1","article-title":"Pharmacologic overview of Withania somnifera, the Indian Ginseng","volume":"72","author":"Dar","year":"2015","journal-title":"Cell Mol Life Sci"},{"key":"2025121400141917000_15.4.e094526.24","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1080\/19390211.2020.1741484","article-title":"Pharmacological evaluation of Ashwagandha highlighting its healthcare claims, safety, and toxicity aspects","volume":"18","author":"Mandlik Ingawale","year":"2021","journal-title":"J Diet Suppl"},{"key":"2025121400141917000_15.4.e094526.25","article-title":"Efficacy and Safety of Ashwagandha (Withania somnifera) Root Extract in Insomnia and Anxiety: A Double-blind, Randomized, Placebo-controlled Study","volume":"11","author":"Langade","year":"2019","journal-title":"Cureus"},{"key":"2025121400141917000_15.4.e094526.26","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaim.2023.100859","article-title":"Clinical safety and tolerability evaluation of Withania somnifera (L.) Dunal (Ashwagandha) root extract in healthy human volunteers","volume":"15","author":"Vaidya","year":"2024","journal-title":"J Ayurveda Integr Med"},{"key":"2025121400141917000_15.4.e094526.27","unstructured":"The Ayurvedic Pharmacopoeia of India - Part I. New Delhi: Ministry of Health and Family Welfare, Government of India, 2011."},{"key":"2025121400141917000_15.4.e094526.28","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01494-2020","article-title":"The Post-COVID-19 Functional Status scale: a tool to measure functional status over time after COVID-19","volume":"56","author":"Klok","year":"2020","journal-title":"Eur Respir J"},{"key":"2025121400141917000_15.4.e094526.29","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00141-2021","article-title":"Recovery from COVID-19: a sprint or marathon? 6-month follow-up data from online long COVID-19 support group members","volume":"7","author":"Vaes","year":"2021","journal-title":"ERJ Open Res"},{"key":"2025121400141917000_15.4.e094526.30","unstructured":"Placebo-controlled study evaluating vortioxetine for cognitive deficits in persons with post-covid-19 syndrome. In: Annals of general psychiatry. 2021."},{"key":"2025121400141917000_15.4.e094526.31","unstructured":"Study of the effectiveness of a cardiorespiratory telerehabilitation program in persistent covid-19 patients. In: Randomized Clinical Trial. 2021."},{"key":"2025121400141917000_15.4.e094526.32","doi-asserted-by":"crossref","DOI":"10.1186\/s12955-021-01691-2","article-title":"Construct validity of the Post-COVID-19 Functional status scale in adult subjects with COVID-19","volume":"19","author":"Machado","year":"2021","journal-title":"Health Qual Life Outcomes"},{"key":"2025121400141917000_15.4.e094526.33","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s11136-018-1785-8","article-title":"Measurement invariance and general population reference values of the PROMIS Profile 29 in the UK, France, and Germany","volume":"27","author":"Fischer","year":"2018","journal-title":"Qual Life Res"},{"key":"2025121400141917000_15.4.e094526.34","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000004817"},{"key":"2025121400141917000_15.4.e094526.35","doi-asserted-by":"publisher","DOI":"10.1378\/chest.93.3.580"},{"key":"2025121400141917000_15.4.e094526.36","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-011-9903-x"},{"key":"2025121400141917000_15.4.e094526.37","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/S0140-6736(14)62456-9","article-title":"The Preventive Antibiotics in Stroke Study (PASS): a pragmatic randomised open-label masked endpoint clinical trial","volume":"385","author":"Westendorp","year":"2015","journal-title":"The Lancet"},{"key":"2025121400141917000_15.4.e094526.38","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2007764"},{"key":"2025121400141917000_15.4.e094526.39","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S1473-3099(23)00440-1","article-title":"Where are the long COVID trials?","volume":"23","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"2025121400141917000_15.4.e094526.40","doi-asserted-by":"crossref","unstructured":"Knuppel A , Boyd A , Macleod J , et al . The long covid evidence gap: comparing self-reporting and clinical coding of long covid using longitudinal study data linked to healthcare records. Epidemiology (Sunnyvale) 2023. doi:10.1101\/2023.02.10.23285717","DOI":"10.1101\/2023.02.10.23285717"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2024-094526","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T08:14:30Z","timestamp":1765700070000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2024-094526"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":40,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4,25]]},"published-print":{"date-parts":[[2025,4]]}},"alternative-id":["10.1136\/bmjopen-2024-094526"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2024-094526","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4]]}}}